Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.583
-0.036 (-5.82%)
At close: Dec 20, 2024, 4:00 PM
0.588
+0.005 (0.79%)
After-hours: Dec 20, 2024, 4:04 PM EST
Company Description
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus.
It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.
It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Cosmos Health Inc.
| Country | United States |
| Founded | 2009 |
| IPO Date | Dec 13, 2013 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 123 |
| CEO | Grigorios Siokas |
Contact Details
Address: 141 West Jackson Boulevard, Suite 4236 Chicago, Illinois 60604 United States | |
| Phone | 312 536 3102 |
| Website | cosmosholdingsinc.com |
Stock Details
| Ticker Symbol | COSM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001474167 |
| CUSIP Number | 221413206 |
| ISIN Number | US2214133058 |
| Employer ID | 27-0611758 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Grigorios Siokas | Chairman and Chief Executive Officer |
| Georgios Terzis | Chief Financial Officer |
| Nikolaos Bardakis | Chief Operating Officer |
| Demetrios G. Demetriades | Secretary and Independent Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 18, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Dec 18, 2024 | 424B3 | Prospectus |
| Dec 13, 2024 | EFFECT | Notice of Effectiveness |
| Dec 10, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 27, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 21, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 14, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 12, 2024 | 8-K | Current Report |